A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults
Clinical trial NCT05351086 · COMPLETED
Trial details
- NCT number
- NCT05351086
- Sponsor
- Pulmatrix Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-09
- Primary completion
- 2022-09-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.